## Abstract ## BACKGROUND Current treatment regimens for Waldenström macroglobulinemia (WM) are based on the use of oral alkylating agents. Recently, however, other more costly agents have been proposed for the treatment of WM. In the current study, the authors report on results obtained using ora
Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma
✍ Scribed by Antonio Palumbo; Alessandra Bertola; Pellegrino Musto; Tommaso Caravita; Vincenzo Callea; Martina Nunzi; Mariella Grasso; Patrizia Falco; Clotilde Cangialosi; Mario Boccadoro
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 86 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Melphalan & Prednisone (MP) is considered as the standard therapy for Multiple Myeloma (MM) patients not eligible for high‐dose therapy. Here, we report the results of a phase I–II study to evaluate the feasibility and efficacy of the association of PLD to the conventional MP regimen du
## Abstract A study was designed to evaluate the effectiveness of prednisone therapy in poor‐risk patients with multiple myeloma. Patients were treated with melphalan alone or in combination with prednisone at doses of either 0.6 mg/kg or 0.3 mg/ kg. The group of patients receiving melphalan and pr
## Abstract ## Background. Body image is a critical psychosocial issue for patients facing treatment for oral cancer, yet there is limited research conducted in this area. This study uses a multidimensional approach to body image assessment and evaluates relationships between body image, demograph